Ondine Biomedical Inc.
|
|||
| Mailing Address: | 1100 Melville Street Suite 888 Vancouver, BC V6E4A6 |
Head Office Address: | 1100 Melville Street Suite 888 Vancouver, BC V6E4A6 |
| Contact Name: | Carolyn Cross | Principal Regulator: | Non-Reporting Issuer |
| Business e-mail address: | ccross@ondinebio.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 604 669-0555 | Reporting Jurisdictions: | Non-Reporting Issuer |
| Fax Number: | 604 669-0533 | Stock Exchange: | London-AIM |
| Date of Formation: | Sep 9 1996 | Stock Symbol: | |
| Jurisdiction Where Formed: | British Columbia | Auditor: | PricewaterhouseCoopers LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 68234 | Transfer Agent: | Computershare Investor Services Inc. |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
